The negative GH auto-feedback in childhood: effects of rhGH and/or GHRH on the somatotroph response to GHRH or hexarelin, a peptidyl GH secretagogue, in children
- PMID: 10803472
- DOI: 10.1007/BF03343699
The negative GH auto-feedback in childhood: effects of rhGH and/or GHRH on the somatotroph response to GHRH or hexarelin, a peptidyl GH secretagogue, in children
Abstract
Aim of the present study was to further clarify the negative GH auto-feedback mechanisms in childhood. To this goal we studied the effects of rhGH and/or GHRH administration on the GH response to GHRH or hexarelin (HEX), a peptidyl GH secretagogue, in normal short children. In 34 prepubertal children (12 girls and 22 boys, age 8.2- 14.2 yr) with normal short stature (normal height velocity and IGF-I levels) the following tests were performed: group A (no.=11): GHRH (GHRH 1 - 29, Geref, Serono; 1 microg/kg iv at 150 min) preceded by saline or GHRH at 0 min; group B (no.=6): GHRH preceded by saline or rhGH (0.005 IU/kg iv at 0 min); group C (no.=6): GHRH preceded by rhGH alone or combined with GHRH; group D (no.=6): HEX (2 microg/kg iv at 150 min) alone or preceded by rhGH. In group A, the GH response to GHRH was not modified by pre-treatment with GHRH (GH peak, mean+/-SEM: 16.7+/-2.9 vs 15.1+/-2.3 microg/l, respectively). In group B, the GH response to GHRH was clearly inhibited by rhGH (8.7+/-2.3 vs 38.8+/-4.5 microg/l, p<0.001); the GH rise after rhGH in group B overlapped with that after GHRH in group A. In group C, the GH response to GHRH after pre-treatment with rhGH (13.2+/-4.0 microg/l) was similar to that in group B and was not significantly modified by pre-treatment with rhGH+ GHRH (6.9+/-2.7 microg/l); the GH rise after rhGH+GHRH was higher (p<0.05) than that after rhGH alone. In group D, the GH response to HEX was significantly blunted by pre-treatment with rhGH (34.1+/-11.7 vs 51.2+/-17.9 microg/l, p<0.05). Our results demonstrate that in childhood the somatotroph response to GHRH is preserved after GHRH while it is inhibited after rhGH administration, which is also able to blunt the GH response to HEX. Thus, the somatostatin-mediated negative GH auto-feedback is already operative in childhood; the reason why the GHRH- induced GH rise is not inhibited by GHRH pre-treatment is unexplained.
Similar articles
-
Mechanisms underlying the negative growth hormone (GH) autofeedback on the GH-releasing effect of hexarelin in man.Metabolism. 1997 Jan;46(1):83-8. doi: 10.1016/s0026-0495(97)90173-6. Metabolism. 1997. PMID: 9005975 Clinical Trial.
-
Effects of recombinant human insulin-like growth factor I administration on growth hormone (GH) secretion, both spontaneous and stimulated by GH-releasing hormone or hexarelin, a peptidyl GH secretagogue, in humans.J Clin Endocrinol Metab. 1999 Jan;84(1):285-90. doi: 10.1210/jcem.84.1.5386. J Clin Endocrinol Metab. 1999. PMID: 9920097 Clinical Trial.
-
Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone.J Clin Endocrinol Metab. 2001 Mar;86(3):1169-74. doi: 10.1210/jcem.86.3.7314. J Clin Endocrinol Metab. 2001. PMID: 11238504 Clinical Trial.
-
Age-related growth hormone-releasing activity of growth hormone secretagogues in humans.Acta Paediatr Suppl. 1997 Nov;423:92-6. doi: 10.1111/j.1651-2227.1997.tb18383.x. Acta Paediatr Suppl. 1997. PMID: 9401552 Review.
-
Clinical applications of recombinant human growth hormone in adults.Expert Opin Pharmacother. 1999 Nov;1(1):97-107. doi: 10.1517/14656566.1.1.97. Expert Opin Pharmacother. 1999. PMID: 11249568 Review.
Cited by
-
Evaluation of growth hormone response to GHRH plus arginine test in children with idiopathic short stature: role of peak time.J Endocrinol Invest. 2018 Aug;41(8):977-983. doi: 10.1007/s40618-017-0824-6. Epub 2018 Feb 8. J Endocrinol Invest. 2018. PMID: 29423542
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources